Envestnet Portfolio Solutions Inc. Raises Position in CME Group Inc. $CME

Envestnet Portfolio Solutions Inc. boosted its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 16.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 70,325 shares of the financial services provider's stock after buying an additional 10,005 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in CME Group were worth $14,809,000 at the end of the most recent quarter.

• Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike

Several other institutional investors have also recently made changes to their positions in CME. BlackRock Inc. purchased a new stake in CME Group in the second quarter worth $6,749,965,000. Norges Bank purchased a new stake in shares of CME Group during the fourth quarter valued at $1,523,241,000. Bank of New York Mellon Corp bought a new position in shares of CME Group in the second quarter worth about $867,313,000. Alphabet Inc. purchased a new position in CME Group in the 2nd quarter worth about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in CME Group during the 2nd quarter valued at about $629,771,000. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Piper Sandler lowered their price objective on shares of CME Group from $329.00 to $295.00 and set an "overweight" rating for the company in a research report on Wednesday, July 15th. TD Cowen reiterated a "buy" rating and issued a $292.00 price target on shares of CME Group in a report on Thursday, September 3rd. Raymond James Financial reissued an "outperform" rating and issued a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. JPMorgan Chase & Co. raised their price objective on CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a report on Thursday, July 23rd. Finally, Erste Group Bank lowered CME Group from a "buy" rating to a "hold" rating in a research report on Friday, June 5th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $289.75.

• Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit

Read Our Latest Analysis on CME Group

Insider Transactions at CME Group

In other CME Group news, Director Elizabeth A. Cook sold 500 shares of the firm's stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the transaction, the director directly owned 17,916 shares of the company's stock, valued at approximately $5,018,450.76. This trade represents a 2.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 15,000 shares of the company's stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the sale, the chief executive officer directly owned 40,630 shares in the company, valued at approximately $11,150,497.20. The trade was a 26.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.30% of the company's stock.

More CME Group News

• Higher-for-Longer Rates Could Reward These 3 Overlooked Stocks

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: New Bitcoin Cash and Uniswap futures could expand trading revenue. CME plans to launch standard and Micro Bitcoin Cash (BCH) and Uniswap (UNI) futures on October 19, pending regulatory review. The contracts give institutional investors regulated exposure to two additional digital assets and could increase trading volume, clearing activity and fee revenue. CME’s crypto derivatives business has already generated significant activity in 2026. CME Group to Launch Bitcoin Cash and Uniswap Futures on October 19
• Positive Sentiment: Investor interest in the new contracts was immediately visible. Bitcoin Cash rallied sharply after CME announced the planned futures, while Uniswap also gained. Although the token moves do not directly determine CME’s earnings, they suggest strong initial market attention and may support demand for CME’s regulated crypto products. Bitcoin Cash, Uniswap Surges as CME Announces New Futures Contracts
• Positive Sentiment: Seth Klarman’s Baupost Group established a sizable CME position. Second-quarter 13F filings show Baupost bought approximately 619,000 CME shares valued at about $136.7 million. The purchase may improve sentiment by signaling confidence in CME’s durable competitive position and cash-generating business. Value Investing Legend Seth Klarman’s New Non-AI Picks
• Neutral Sentiment: CME is broadening its equity-derivatives lineup. New factor futures are designed to provide targeted exposure, margin offsets and flexible implementation for institutional investors, potentially strengthening CME’s product ecosystem. CME Group Expands Equity Derivatives With New Factor Futures
• Negative Sentiment: Crypto-product demand remains uncertain. BCH’s rally could attract speculative interest, but similar futures announcements have reportedly been followed by declines in some underlying tokens. The October launches also require regulatory approval, and volatile or weak crypto trading could limit sustained volume and revenue. Bitcoin Cash Rallies 30% Following CME Futures Announcement

CME Group Stock Up 1.3%

NASDAQ:CME opened at $270.80 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a market cap of $97.37 billion, a PE ratio of 22.97, a P/E/G ratio of 3.16 and a beta of 0.24. The company's 50 day moving average is $268.69 and its two-hundred day moving average is $274.61.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the company earned $2.96 earnings per share. Analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 44.11%.

About CME Group

(Free Report)

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company's principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.

Recommended Stories

• Five stocks we like better than CME Group
• Chips to Bots: Qualcomm’s Agentic AI Breakout
• Ciena Fell 40%—Now One Analyst Sees 50% Upside
• Energy Transfer Taps the AI Power Boom
• Viking's Obesity Edge May Be Staying Power, Not Weight Loss

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here